Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. Ann Clin Transl Neurol. 2021;8:1073–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102–7.

Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. Persistent symptoms after Covid-19: qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Serv Res. 2020;20(Dec):1144.

Article  PubMed  PubMed Central  Google Scholar 

Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020;7(Nov):2221–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(Aug):E1060–70.

PubMed  PubMed Central  Google Scholar 

Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Vol. 88. Annals of Neurology. John Wiley and Sons Inc.; 2020. p. 1–11.

Hanson BA, Visvabharathy L, Ali ST, Kang AK, Patel TR, Clark JR. et al. Plasma biomarkers of neuropathogenesis in hospitalized patients with COVID-19 and those with postacute sequelae of SARS-CoV-2 infection. Neurol(R) Neuroimmunol Neuroinflamm. 2022;9:e1151

Article  Google Scholar 

del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. J Am Med Assoc. 2020;324:1723–4.

Article  Google Scholar 

Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. Neuropsychiatric complications of covid-19. Vol. 371, The BMJ. BMJ Publishing Group; 2020.

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(May):416–27.

Article  PubMed  PubMed Central  Google Scholar 

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(Jan):220–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(Sep):e1003773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Solomon T. Neurological infection with SARS-CoV-2—the story so far. Vol. 17. Nature Reviews Neurology. Nature Research; 2021. p. 65–6.

Theoharides TC. Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome? Vol. 59. Molecular Neurobiology. Springer; 2022. p. 1850–61.

The Lancet. Facing up to long COVID. Vol. 396, The Lancet. Lancet Publishing Group; 2020. p. 1861.

Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Vol. 14. Nature Reviews Neurology. Nature Publishing Group; 2018. p. 577–89.

Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. Journal of Neurology, Neurosurgery and Psychiatry. BMJ Publishing Group; 2019.

Hendricks R, Baker D, Brumm J, Davancaze T, Harp C, Herman A, et al. Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood. Bioanalysis. 2019;11:1405–18.

Article  CAS  PubMed  Google Scholar 

Delcoigne B, Manouchehrinia A, Barro C, Benkert P, Michalak Z, Kappos L, et al. Blood neurofilament light levels segregate treatment effects in multiple sclerosis. Neurology. 2020;94:e1201–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moscoso A, Grothe MJ, Ashton NJ, Karikari TK, Lantero Rodríguez J, Snellman A, et al. Longitudinal associations of blood phosphorylated Tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease. JAMA Neurol. 2021;78:396–406.

Article  PubMed  Google Scholar 

Fisse AL, Pitarokoili K, Leppert D, Motte J, Pedreiturria X, Kappos L, et al. Serum neurofilament light chain as outcome marker for intensive care unit patients. J Neurol. 2021;268:1323–9.

Article  CAS  PubMed  Google Scholar 

Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, et al. Serum neurofilament light chain for prognosis of outcome after cardiac arrest. JAMA Neurol. 2019;76(Jan):64–71.

Article  PubMed  Google Scholar 

Cooper J, Stukas S, Hoiland RL, Fergusson NA, Thiara S, Foster D, et al. Quantification of neurological blood-based biomarkers in critically Ill patients with coronavirus disease 2019. Crit Care Explor. 2020;2(Oct):e0238.

Article  PubMed  PubMed Central  Google Scholar 

Ameres M, Brandstetter S, Toncheva AA, Kabesch M, Leppert D, Kuhle J, et al. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. Vol. 267, Journal of Neurology. Springer Science and Business Media Deutschland GmbH; 2020. p. 3476–8.

Hay M, Ryan L, Huentelman M, Konhilas J, Hoyer-Kimura C, G Beach T, et al. Serum neurofilament light is elevated in COVID-19 positive adults in the ICU and is associated with co-morbid cardiovascular disease, neurological complications, and acuity of illness. Cardiol Cardiovasc Med. 2021;05:551–65.

Article  Google Scholar 

Saller T, Petzold A, Zetterberg H, Kuhle J, Chappell D, von Dossow V, et al. A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients. Biomed Pap. 2019;163:241–6.

Article  Google Scholar 

Marchegiani F, Recchioni R, Marcheselli F, di Rosa M, Sabbatinelli J, Matacchione G, et al. Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19. Journal of Neurology. Springer Science and Business Media Deutschland GmbH; 2022.

De Lorenzo R, Loré NI, Finardi A, Mandelli A, Cirillo DM, Tresoldi C, et al. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J Neurol. 2021;268:4436–42.

Article  PubMed  PubMed Central  Google Scholar 

Prudencio M, Erben Y, Marquez CP, Jansen-West KR, Franco-Mesa C, Heckman MG, et al. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci Transl Med 2021;13:eabi7643.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masvekar RR, Kosa P, Jin K, Dobbs K, Stack MA, Castagnoli R, et al. Prognostic value of serum/plasma neurofilament light chain for COVID-19-associated mortality. Ann Clin Transl Neurol. 2022;9:622–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aamodt AH, Høgestøl EA, Popperud TH, Holter JC, Dyrhol-Riise AM, Tonby K, et al. Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19. J Neurol. 2021;268:3574–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwok KO, Huang Y, Tsoi MTF, Tang A, Wong SYS, Wei WI, et al. Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region. Respirology. 2021;26:322–33.

Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, et al. SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID syndrome in mice. Cell Rep. 2023;42:112189 https://linkinghub.elsevier.com/retrieve/pii/S2211124723002000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith A. Symbol digit modalities test (SDMT). Manual (Revised). Los Angeles: Western Psychological Services; 1982.

Giménez-Garzó C, Garcés JJ, Urios A, Mangas-Losada A, García-García R, González-López O, et al. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. PLoS ONE. 2017;12:e0171211.

Article  PubMed  PubMed Central  Google Scholar 

Sheridan LK, Fitzgerald HE, Adams KM, Nigg JT, Martel MM, Puttler LI, et al. Normative symbol digit modalities test performance in a community-based sample. Arch Clin Neuropsychol. 2006;21:23–8.

Article  PubMed  Google Scholar 

Parmenter BA, Testa SM, Schretlen DJ, Weinstock-Guttman B, Benedict RHB. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2010;16:6–16.

Article  PubMed  Google Scholar 

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.

Mazza MG, Palladini M, Villa G, de Lorenzo R, Rovere Querini P, Benedetti F. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J Psychiatr Res. 2022;155:112–9.

Article  PubMed  PubMed Central  Google Scholar 

Grover S, Sahoo S, Mishra E, Gill KS, Mehra A, Nehra R, et al. Fatigue, perceived stigma, self-reported cognitive deficits and psychological morbidity in patients recovered from COVID-19 infection. Asian J Psychiatr. 2021;64:102815.

Article  PubMed  PubMed Central  Google Scholar 

Sarda R, Kumar A, Chandra A, Bir M, Kumar S, Soneja M, et al. Prevalence of Long COVID-19 and its Impact on Quality of Life Among Outpatients With Mild COVID-19 Disease at Tertiary Care Center in North India. J Patient Exp. 2022;9;1–7.

Cristillo V, Pilotto A, Piccinelli SC, Gipponi S, Leonardi M, Bezzi M, et al. Predictors of “brain fog” 1 year after COVID-19 disease. Neurol Sci. 2022;43:5795–7.

Article  PubMed  PubMed Central  Google Scholar 

Krishnan K, Miller AK, Reiter K, Bonner-Jackson A. Neurocognitive profiles in patients with persisting cognitive symptoms associated with COVID-19. Arch Clin Neuropsychol. 2022;37:729–37.

Article  PubMed  Google Scholar 

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

Fernández-de-las-Peñas C, Rodríguez-Jiménez J, Palacios-Ceña M, de-la-Llave-Rincón AI, Fuensalida-Novo S, Florencio LL, et al. Psychometric properties of the hospital anxiety and depression scale (HADS) in previously hospitalized COVID-19 patients. Int J Environ Res Public Health. 2022;19:9273.

Article  PubMed  PubMed Central  Google Scholar 

Bjelland I, Dahl AA, Haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77.

Shanbehzadeh S, Tavahomi M, Zanjari N, Ebrahimi-Takamjani I, Amiri-Arimi S. Physical and mental health complications post-COVID-19: scoping review. Vol. 147. Journal of Psychosomatic Research. Elsevier Inc.; 2021.

Liu C, Pan W, Li L, Li B, Ren Y, Ma X. Prevalence of depression, anxiety, and insomnia symptoms among patients with COVID-19: a meta-analysis of quality effects model. Vol. 147. Journal of Psychosomatic Research. Elsevier Inc.; 2021.

Olssøn I, Mykletun A, Dahl AA. The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46.

Article  PubMed  PubMed Central  Google Scholar 

Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023;115:233–43.

PubMed